Corcept Therapeutics | CORT - Выручка от реализации

Биржевая цена
41.91
Изменение за день
-0.34 -0.80%
Ежемесячно
24.21%
Ежегодный
-38.92%
Q2 прогноз
41.21




Продажи Изменить Дата
Acadia Pharmaceuticals USD 284M 5.4M 2025-12
Alaunos Therapeutics USD 2K 2K 2025-03
ANI Pharmaceuticals USD 247.06M 19.25M 2025-12
Ardelyx USD 125.21M 14.89M 2025-12
Assertio Holdings USD 29.2M 1.92M 2024-09
Aurora Cannabis CAD 94.19M 3.82M 2025-12
BioMarin Pharmaceutical USD 875M 99M 2025-12
Bristol-Myers Squibb USD 12.5B 300M 2025-12
Canopy Growth CAD 74.54M 7.86M 2025-12
Corcept Therapeutics USD 202.12M 5.48M 2025-12
Eli Lilly USD 19.3B 1.7B 2025-12
Esperion Therapeutics USD 168.45M 81.14M 2025-12
J&J USD 24.6B 610M 2025-12
Knight Therapeutics CAD 133.11M 11.56M 2025-12
Lexicon Pharmaceuticals USD 5.49M 8.69M 2025-12
Merck USD 16.4B 880M 2025-12
Nektar Therapeutics USD 21.81M 2.32M 2025-12
Novartis USD 13.86B 50M 2025-12
Novartis USD 13.86B 498M 2025-12
Pacira USD 196.87M 17.35M 2025-12
Pfizer USD 17.58B 880M 2025-12
Supernus Pharmaceuticals USD 211.6M 19.5M 2025-12
TG Therapeutics USD 192.57M 30.87M 2025-12